Navigation Links
Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors

the FDA and the first approved treatment for all five subtypes of MDS.

The combination of azacitidine (Vidaza) and valproic acid is safe and active in advanced solid tumors - A.O. Soriano; Abstract #3547; June 2, 2007; 2-6pm; McCormick Place Convention Center, S102a

Results were reported this afternoon from a Phase I study of Azacitidine, a DNA hypomethylating agent, in combination with valproic acid, an HDAC inhibitor, in patients with advanced solid tumors. The study, which included patients with advanced forms of 10 different solid tumors, evaluated the safety and activity of the two compounds in combination.

Of 55 evaluable patients, 14 patients, or 25 percent, were observed to experience stable disease in a variety of advanced solid tumors. The duration of the patients' stable disease was four to 12 months, with a median of six months.

These data show that the combination of the two compounds was safe and active in patients with advanced solid tumors The data also indicated that the maximum tolerated dose of azacitidine when used in the combination was 75 mg/m2. Significant global DNA hypomethylation and histone acetylation were demonstrated.

Data Presented Saturday, June 2

Phase I/II study of a novel oral isotype-selective histone deacetylase (HDAC) inhibitor MGCD0103 in combination with Azacitidine in patients (pts) with high-risk Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia (AML) - G. Garcia-Manero, MD, MD Anderson Cancer Center; Abstract #7062; June 2, 2007; 8:00-12:00 pm; McCormick Convention Center, S Hall A2

The combination of 5-azacytidine and valproic acid is safe and active in advanced solid tumors - A.O. Soriano, MD Anderson Cancer Center; Abstract #3547; June 2, 2007; 2:00-6:00pm; McCormick Place Convention Center, S102a

Tolerability and hematologic improvement assessed using three alternative dosing schedules of azacitidine (Vidaza) in patients with MDS - R. Lyons, US Oncology;
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:12/16/2009)... CareCentrix, Inc ., the nation,s leading provider of ... it has been awarded Health Utilization Accreditation from ... that establishes quality standards for the health care ... qualified clinical personnel conduct and oversee the utilization ... process is in place, and that medical decisions ...
(Date:12/16/2009)... Biovista Inc.,today announced that it was ... at the 2009 New England Venture Summit, held ... recognizes cutting edge private companies,driving the future of ... 50 other privately held companies that play a ... and Clean-tech sectors. , ...
(Date:12/16/2009)... 16 GlaxoSmithKline plc [GSK] (NYSE: ... an exclusive licensing agreement in the United States ... NB-001, a novel, patented compound representing the next ... by NanoBio, NB-001 provides significant antimicrobial activity against ... labialis . ,, Cold sores are a ...
Breaking Medicine Technology:CareCentrix Receives URAC Health Utilization Management Accreditation 2Biovista Inc. Named Top Innovator in Life Sciences 2GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment 2Celebrate Darwins bicentennial by exploring how Darwin defined evolutionary biology 10192 1Celebrate Darwins bicentennial by exploring how Darwin defined evolutionary biology 10192 2First human gets new antibody aimed at rabies virus 10189 1First human gets new antibody aimed at rabies virus 10189 2First human gets new antibody aimed at rabies virus 10189 3Global Regulators to Discuss Benefit Risk Approaches of Medicinal Products at DIA Workshop 58566 1Global Regulators to Discuss Benefit Risk Approaches of Medicinal Products at DIA Workshop 58566 2Global Regulators to Discuss Benefit Risk Approaches of Medicinal Products at DIA Workshop 58566 3
... relapsed / refractory acute myelogenous leukemia-PRINCETON, N.J., May 27 ... today the allowance of an investigational new drug application ... (FDA) for MDX-1338, for the treatment of patients with ... antibody that targets CXCR4, a chemokine receptor found on ...
... maintenance service delivers Germ-Free cleaning, extending life, efficiency and ... Some people are almost neurotic about washing their hands ... they sit at their computer and put their hands ... perfect breeding ground for these persistent little bugs, which ...
Other Medicine Technology:Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338 2Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338 3GreenBytes Wards Off Germs and Costly Computer Repairs 2GreenBytes Wards Off Germs and Costly Computer Repairs 3
(Date:12/17/2009)... the past three years and what has driven these changes ... ... the human capital research firm, will host a webinar titled “The ... hour-long webinar will be broadcast on Wednesday, January 27, 2010 at ... SVP, Consulting Services and Trevor Byrd, Ph.D., a Morehead Consultant, as ...
(Date:12/17/2009)... Specific Neurological Stress Reduction Therapy or NSRTSM is found very ... conditions such as allergies, asthma, migraines, chronic fatigue and a ... throughout the country are using this holistic therapy including over ... ... Allentown, PA (Vocus) December 16, 2009 -- ...
(Date:12/17/2009)... free i-phone & i-touch application directly in the hands ... , ... (PRWEB) ... & Coaching is bringing a new touch to 2010. ... little hand held device. Movies, music, news? Does not ...
(Date:12/16/2009)... care sector revenue increased by 5.7 percent in ... in 2007, according to new data from the ... the North American Industry Classification System as NAICS ... figures come from the 2008 Service Annual ... series of tables which provides estimates of revenue, ...
(Date:12/16/2009)... Benefit of Children with Autism and Other Special Needs, ... Zachary Levi Join Ben Stiller to Ring in the ... -- At its 13th annual Teddy Bear Ball, The ... & CEO Brian Goldner received the ... far-reaching philanthropic leadership and commitment to children,s causes; ...
Breaking Medicine News(10 mins):Health News:Morehead Presents Webinar on "The State of Employee Engagement: A Year in Review" 2Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 5Health News:Attainment Life Management & Coaching has just Debuted its Free Application for I-Phone and I-Touch Users 2Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 2Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 2Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 4Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 5
... contains genetic variations strongly associated with familial lung cancer, ... School of Medicine in St. Louis and other institutions ... The researchers found a more than five times higher ... a family history of the disease and these genetic ...
... various groups, many hospitals still giving them to new ... to a new study, the majority of East Coast ... even though most major medical organizations oppose this practice. ... of the Archives of Pediatrics & Adolescent ...
... from prior team, DELRAY BEACH, Fla., Sept. 9 ... an important addition to,its board of directors. Mr. Geary ... the two persons that Mr. Carl DeSantis has the ... and CDS Ventures of South,Florida, LLC. Mr. Cotton has ...
... TARRYTOWN, N.Y., Sept. 9 Focus 28, Inc. ... its new next generation line of,meal replacements and ... of bariatric patients. According to the company,Bariatric RX ... food,supplements also utilize Double A Technology (AAT), a ...
... push for broad-based admission policies that reflect ethnic variety ... schools with high levels of racial and ethnic diversity ... minority patients, U.S. researchers say. , The study analyzed ... students from 118 medical schools. It found that white ...
... Studies Find Dramatic Increase in Suicides among Adolescent,African-American ... increase in,mental illness and behavioral problems among adolescent ... treatment and better,understanding of the complex challenges facing ... Community Voices: Healthcare for the Underserved, an,advocacy group ...
Other Medicine News:Health News:Genetic region linked to a 5 times higher lung cancer risk 2Health News:Genetic region linked to a 5 times higher lung cancer risk 3Health News:Formula Samples Hinder Breast-Feeding Efforts 2Health News:Celsius Strengthens Board With Prior Rexall Sundown CFO 2Health News:Focus 28 Begins Shipping Next Generation Line of Meal Replacements and Food Supplements for Bariatric Patients 2Health News:Med School Diversity May Help Whites Care Better for Minorities 2Health News:Med School Diversity May Help Whites Care Better for Minorities 3Health News:Young African-American Males Face Mental Health Crisis; Experts Call For New Treatment Strategies and Better Access to Care 2Health News:Young African-American Males Face Mental Health Crisis; Experts Call For New Treatment Strategies and Better Access to Care 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: